Category Archives: Endocrinology

Second-line drugs in diabetes

I love studies that explore the practical questions we wrestle with in day-to-day work. So, I was pleased to see the BMJ study ‘Sulfonylureas for type 2 diabetes‘ (Douros et al). The presentation of the results in the written journal … Continue reading

Posted in Credits 2018, Diabetes, Medication | Leave a comment

Remission of diabetes?

I’ve often wondered what happens if a diabetic person actually makes significant enough lifestyle changes to bring their blood glucose down into the non-diabetic range; since diabetes is diagnosed based on glucose levels, would this mean that this person had … Continue reading

Posted in Credits 2017, Diabetes, Endocrinology | Leave a comment

Diabetes in pregnancy

Affects approximately 5% of pregnant women, of whom over 80% have gestational diabetes and the rest had pre-existing DM of either type. Screening NICE recommends screening the following high-risk groups: BMI >30 Previous baby 4.5 kg or over Previous gestational … Continue reading

Posted in Diabetes, Endocrinology, Pregnancy and Childbirth | Leave a comment

Bits and bobs

Useful bunch of motley learning points from the 15th April BMJ: A double-blind trial reported in NEJM has looked at the effects of treating borderline thyroid results (raised TSH with normal T4) in the elderly. It didn’t show any benefit … Continue reading

Posted in BMJ, Cardiovascular, Credits 2017, Endocrinology, Hypertension, Medication, Paediatrics, Thyroid | Leave a comment

Diabetes presentation

Went to the practice clinical meeting, which was about diabetes this time and mainly focused on new diabetes drugs, as well as going over the NICE guidelines. The meds covered were incretin-based therapies (GLT-1 agonists and DPP-4 inhibitors) which I … Continue reading

Posted in Diabetes, Medication | Leave a comment

NICE guidance on diabetes – December 2015

Blood pressure management in diabetes If no history of hypertension or renal disease, check annually. If controlled hypertension, check every 4 – 6 months (that’ll be a nice bit of extra work for somebody. Pun not intended.) Remember lifestyle advice. … Continue reading

Posted in Diabetes, Endocrinology | Leave a comment

Rational prescribing

From our CCG’s review of evidence (Rational Prescribing, Sept 2015): On current evidence (which admittedly is somewhat limited), there is no statistically significant benefit from treating Stage 1 hypertension (160/100 or less) Aiming for an HbA1c level of 7.0% vs. … Continue reading

Posted in Credits 2016, Diabetes, Hypertension, Medication, Nephrology | Leave a comment